Release of human serum albumin from poly(lactide-co-glycolide) microspheres.
about
Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazidA novel in vitro release technique for peptide containing biodegradable microspheresInfluence of morphology and drug distribution on the release process of FITC-dextran-loaded microspheres prepared with different types of PLGA.Modulation of stem cell differentiation with biomaterials.Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophagesSingle-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen.Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected miceAmoxicillin-bearing microparticles: potential in the treatment of Listeria monocytogenes infection in Swiss albino mice.Chitosan microcapsules as controlled release systems for insulin.Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection.Drug delivery from ocular implants.In vitro release of vascular endothelial growth factor from gadolinium-doped biodegradable microspheres.Characterization of reservoir-type microcapsules made by the solvent exchange method.Microparticles produced by the hydrogel template method for sustained drug deliveryProtein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues.Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization.Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems.Quality improvement of spray-dried, protein-loaded D,L-PLA microspheres by appropriate polymer solvent selection.Solvent free production of porous PDLLA/calcium carbonate composite scaffolds improves the release of bone growth factors.Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody.Formulation and characterization of rifampicin microcapsulesControlled release of anti-cocaine catalytic antibody from biodegradable polymer microspheres.Desensitizing mice to ovalbumin through subcutaneous microsphere immunotherapy (SMITH).Branched oligoester microspheres fabricated by a rapid emulsion solvent extraction method.Bioadhesive fluorescent microspheres as visible carriers for local delivery of drugs. II: Uptake of insulin-loaded PCEFB/PLGA microspheres by the gastrointestinal tract.Efficacy of amoxicillin bearing microsphere formulation in treatment of Listeria monocytogenes infection in Swiss albino mice.Improvement of protein loading and modulation of protein release from poly(lactide-co-glycolide) microspheres by complexation of proteins with polyanions.An improvement of double emulsion technique for preparing bovine serum albumin-loaded PLGA microspheres.Preparation of bovine serum albumin loaded poly (D, L-lactic-co-glycolic acid) microspheres by a modified phase separation technique.Effect of poly(ethylene glycol) content and formulation parameters on particulate properties and intraperitoneal delivery of insulin from PLGA nanoparticles prepared using the double-emulsion evaporation procedure.Optimizing double emulsion process to decrease the burst release of protein from biodegradable polymer microspheres.Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs.Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method.In vitro–in vivo correlation from lactide-co-glycolide polymeric dosage forms.Computer modeling assisted design of monodisperse PLGA microspheres with controlled porosity affords zero order release of an encapsulated macromolecule for 3 months.Controlled release of vascular endothelial growth factor from alginate hydrogels nano-coated with polyelectrolyte multilayer films.Protein-loaded poly(epsilon-caprolactone) microparticles. II. Muramyl dipeptide for oral controlled release of adjuvant.Vaccine potential of cytosolic proteins loaded fibrin microspheres of Cryptococcus neoformans in BALB/c mice.
P2860
Q28365194-341FE2DE-565D-4901-B2F3-9ED9361DFB63Q31036246-CAC25764-495F-40C5-BDA8-466EF3EB4422Q33362424-2EF2030C-F28B-4D06-BCBA-8080D49C2C50Q33614866-FDB69C40-F0AA-45C9-B59F-CEDE90C5063EQ33699804-E6C80D0C-2739-4A34-8A69-255677152232Q33868005-C8410CE7-EB6D-40E5-9B9B-076B93AEE6FEQ33976250-D418D81B-B5DF-4D87-BE72-96FD6FCACCE2Q34129867-317C5203-36C3-4256-9D77-156009AA54AFQ34438688-1F69BF9C-5B17-4973-B222-B71FA2CE68D2Q35467763-E52DE937-C979-416D-9E5F-D122AB9632DBQ36409058-DE992A65-3B27-4B9F-B593-C18F4189ECD3Q36676092-E3853186-3915-4D4C-8915-889CC6965197Q37360737-24951C83-1BE2-4818-A5E8-1374450E01DCQ37576526-E07308CF-7AB8-45C8-B347-E79CE8FCB012Q38548963-8A6CDB50-6CB9-46A0-9175-64279F019322Q38550145-E1F51583-F92E-430D-8503-0D8A75112C2DQ38558053-115A0204-2E0F-49D7-968A-C0B2C2FB9F4DQ38573220-EC3FE114-F77F-46A4-B6B8-C6C616C75C13Q38960794-66F9571E-97FE-441F-8CB8-039ECBF52782Q39433325-ADE4F5B6-8FF5-4856-8BE4-941112574AD0Q40965016-729AF2C2-12D1-4716-A72F-9AD015E80358Q43972196-47D7E649-651F-43AB-9B1A-6C65DE3EA096Q44116310-3C875A10-7445-4B5C-A9F1-176879C8C192Q44539381-77B5C409-3DE3-4D85-8D57-12457DE1E891Q45286812-D85F25CB-9379-4FE6-B6F4-03C84DEC3FFAQ45923189-56D1C3FF-EBC5-42CA-8083-DF0B70F548BDQ46372174-8774AABB-9138-4EBB-B7D5-17EADB3E61B8Q46411851-125E0AFA-A21E-43B9-8D11-6BDCF98953D3Q46601013-C427610C-11F1-4984-855C-857FFF88AF15Q46608261-D69DC37C-4FC4-49B0-BDAD-1EEB18933711Q46743893-DC0EADCA-9E06-454D-92F3-0BC4B99EB606Q46976574-913109AB-2E7A-4838-B5FE-5658410717B8Q47889542-AE81AFF9-7F55-4852-B7A7-76CCDEE7A5FEQ49707213-1727EFBE-74F5-47A1-85CA-176778FCBFC3Q50427013-177F1373-7784-40BD-ADB2-696528D98FA0Q50957940-0FDC6F7D-C56A-4ADB-8582-8DF1A9774EA7Q54077958-BF35DD11-69DD-4BE2-8629-7A00E8021CE5Q55056060-0B985429-CFE4-47DC-B371-3135437F7AC9
P2860
Release of human serum albumin from poly(lactide-co-glycolide) microspheres.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Release of human serum albumin from poly
@nl
Release of human serum albumin from poly(lactide-co-glycolide) microspheres.
@en
type
label
Release of human serum albumin from poly
@nl
Release of human serum albumin from poly(lactide-co-glycolide) microspheres.
@en
prefLabel
Release of human serum albumin from poly
@nl
Release of human serum albumin from poly(lactide-co-glycolide) microspheres.
@en
P2093
P356
P1476
Release of human serum albumin from poly(lactide-co-glycolide) microspheres.
@en
P2093
P304
P356
10.1023/A:1015948829632
P577
1990-11-01T00:00:00Z